Oxphos targeting of MYCN-amplified neuroblastoma.

Saved in:
Bibliographic Details
Title: Oxphos targeting of MYCN-amplified neuroblastoma.
Authors: Epp S; Systems Biology Ireland, University College Dublin, School of Medicine, Dublin, Ireland., Egan D; Systems Biology Ireland, University College Dublin, School of Medicine, Dublin, Ireland., Poon E; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Abdul Aziz AA; Systems Biology Ireland, University College Dublin, School of Medicine, Dublin, Ireland., Wynne K; Systems Biology Ireland, University College Dublin, School of Medicine, Dublin, Ireland., Chesler L; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Halasz M; Systems Biology Ireland, University College Dublin, School of Medicine, Dublin, Ireland.; Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland., Kolch W; Systems Biology Ireland, University College Dublin, School of Medicine, Dublin, Ireland.; Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
Source: Frontiers in oncology [Front Oncol] 2025 Oct 24; Vol. 15, pp. 1613751. Date of Electronic Publication: 2025 Oct 24 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2025.1613751